» Articles » PMID: 26349819

Interactions of Klebsiella Pneumoniae with the Innate Immune System Vary in Relation to Clone and Resistance Phenotype

Overview
Specialty Pharmacology
Date 2015 Sep 10
PMID 26349819
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Apart from inadequate antimicrobial treatment, specific virulence factors contribute to the high attributable mortality of infections caused by multidrug-resistant (MDR) Klebsiella pneumoniae. We explored the roles of MDR and clones as virulence determinants of K. pneumoniae and their interaction with innate immunity. Twenty isolates were studied and characterized by resistance phenotype and multilocus sequence type (MLST). Human peripheral blood mononuclear cells (PBMCs) were stimulated for the production of proinflammatory cytokines by live and heat-killed isolates and plasmid DNA; modulation by cellular pathway inhibitors was explored. Survival of 30 mice was recorded after intraperitoneal challenge with susceptible and K. pneumoniae carbapenemase (KPC)-producing isolates. Splenocytes of mice were stimulated for the production of pro- and anti-inflammatory cytokines. Isolates were divided into different patterns of production of tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β) poststimulation in relation to both the MLST clone and resistance phenotype. The sequence type 383 (ST383) clone producing Verona integron-encoded metallo-β-lactamase (VIM) stimulated high production of both TNF-α and IL-1β. Clone ST17 producing KPC elicited low TNF-α production; this was reversed by Toll-like receptor 9 (TLR9) antagonists, indicating an effect of plasmid DNA. This isolate was linked with early death of mice compared to high-TNF-α-producing isolates. We conclude that KPC-producing isolates seem to be highly virulent in a low-TNF-α-release environment, suggesting an immunoparalysis induction mechanism. KPC plasmids may directly contribute to the immune system stimulation.

Citing Articles

First Report of , , and Carrying Showing High-Level Resistance to Carbapenems.

Li S, Shen S, Ding L, Han R, Guo Y, Yin D Front Microbiol. 2022; 13:916304.

PMID: 35875519 PMC: 9301006. DOI: 10.3389/fmicb.2022.916304.


The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy.

Schubert M, Rohrbach R, Schmitt M, Stein-Thoeringer C Front Immunol. 2021; 12:670286.

PMID: 34135898 PMC: 8200823. DOI: 10.3389/fimmu.2021.670286.


Reduced Fitness Costs of Compared to Mutated in Isogenic Colistin-Resistant KPC-3-Producing Klebsiella pneumoniae.

Giordano C, Klak A, Barnini S, Chlebowicz M, Menconi M, Rossen J mSphere. 2019; 4(6).

PMID: 31694895 PMC: 6835208. DOI: 10.1128/mSphere.00551-19.


Genome-based analysis of Carbapenemase-producing isolates from German hospital patients, 2008-2014.

Becker L, Kaase M, Pfeifer Y, Fuchs S, Reuss A, von Laer A Antimicrob Resist Infect Control. 2018; 7:62.

PMID: 29744043 PMC: 5930415. DOI: 10.1186/s13756-018-0352-y.


Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.

Russo A, Giuliano S, Ceccarelli G, Alessandri F, Giordano A, Brunetti G Antimicrob Agents Chemother. 2018; 62(6).

PMID: 29555630 PMC: 5971575. DOI: 10.1128/AAC.02562-17.


References
1.
Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J . Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000; 44(4):891-7. PMC: 89788. DOI: 10.1128/AAC.44.4.891-897.2000. View

2.
Sturenburg E, Mack D . Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect. 2003; 47(4):273-95. DOI: 10.1016/s0163-4453(03)00096-3. View

3.
Giamarellos-Bourboulis E, Plachouras D, Tzivra A, Kousoulas V, Bolanos N, Raftogiannis M . Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: an in vitro and in vivo study. Clin Exp Immunol. 2004; 135(2):240-6. PMC: 1808952. DOI: 10.1111/j.1365-2249.2003.02365.x. View

4.
Bradford P, Bratu S, Urban C, Visalli M, Mariano N, Landman D . Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis. 2004; 39(1):55-60. DOI: 10.1086/421495. View

5.
Kang C, Kim S, Beom Park W, Lee K, Kim H, Kim E . Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005; 49(2):760-6. PMC: 547233. DOI: 10.1128/AAC.49.2.760-766.2005. View